In U.S the more use of high cost medical image practice like positron emission tomography is being determined by the decision of patients who made it after having information from non-experts and mass media but not completely from the health care professionals.
The result is from a three year analysis, which was published in the journal, “ Associations between Cancer-Related Information Seeking and Receiving PET Imaging for Routine Cancer Surveillance – An Analysis of Longitudinal Survey Data.” Which appeared in the journal Cancer Epidemiology, Biomarkers & Prevention. The lead author of the study is Andy S.Tan, Ph. D., a post-doctoral fellow with the university of Pennsylvania’s Annenberg school for communication.
Dr. Tan and the study with other authors says that, “Clinical guidelines do not recommend PET for post-treatment surveillance among asymptomatic cancer survivors.”
It was understood from the studies about what made the cancer patients to get such unsuitable methods, to inform policies or interferences to stop their overuse.
No comments:
Post a Comment